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Introduction: The main objective of individualization of treatment in IVF is to offer every 
single woman the best treatment tailored to her own unique characteristics, thus maximizing the 
chances of pregnancy and eliminating the iatrogenic and avoidable risks resulting from ovarian 
stimulation. Personalization of treatment in IVF should be based on the prediction of ovarian 
response for every individual. The starting point is to identify if a woman is likely to have a normal, 
poor or a hyper response and choose the ideal treatment protocol tailored to this prediction. 
Although anti-Mullerian hormone (AMH) level is known to predict ovarian reserve, there is 
conflicting evidence regarding the association between A M H and clinical pregnancy or live birth 
(LB). 
Our aim is to establish if there is any association between A M H and LB considering the 
effects of age and other relevant confounding factors in predicting LB. 
Methods: 400 in-vitro fertilization (IVF) cycles were retrospectively analyzed in IVF 
department of National research Center of Maternity & Child Care. From the database, data 
regarding the women's age, A M H level, IVF/intracytoplasmic sperm injection, the factors of 
infertility, protocols, median A M H level and live birth rates (LBRs) were compared between the 
groups with and without LB in four age groups. The influences of age and A M H in predicting LB 
were analyzed. 
Results: There were no significant differences in any of the confounding factors analyzed 
between the groups with and without LB. In the higher two age groups, median A M H levels in the 
group with LB were higher than that in the group without LB. The odds of having a LB was 
significantly higher in the younger three age groups, and when A M H level was >20 pmol/l. A M H 
was not found to be the IVF outcome defining factor in younger women, but was relevant in those 
above 35 years. Older women with significantly higher A M H level had significantly higher LBR 
than their peers with low A M H level. 
Conclusion: Personalized IVF offers several benefits; it enables clinicians to give women 
more accurate information on their prognosis thus facilitating counselling. A M H does have a role in 
counselling women when predicting live birth from IVF, although age of women plays a major role 
in determining success from IVF treatment. 
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